February 26, 2010
Local (JPN)

For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Takashi Shoda, President and Representative Director
(Code no.: 4568, First Section, Tokyo, Osaka and Nagoya Stock Exchanges)
Please address inquiries to Toshiaki Sai, General Manager,
Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com/

About the News Report

TOKYO, Japan (February 26, 2010) - It was reported by some media that Daiichi Sankyo Company Limited (hereinafter "Daiichi Sankyo") would enter into the generic drug business in Japan. However, this is not official announcement by Daiichi Sankyo.

While Daiichi Sankyo constantly reviews various possibilities for its further strategic business development, no final decision related to such matter reported today has been made. We will make an announcement if any resolution is to be made.

End